Biocide (PT18) Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Synthetic Biocides, Natural/Bio-based Biocides), By End User (Healthcare, Agriculture, Food & Beverage, Hospitality, Municipal/Government, Others), By Distribution Channel (Direct Sales, Retail Stores, Online Platforms, Distributors/Wholesalers) and Region Forecast 2020-2031

Biocide (PT18) Market size was valued at US$ 473.8 million in 2024 and is expected to reach US$ 693.8 million by 2031, growing at a significant CAGR of 5.6% from 2025-2031. The market refers to the global industry involved in the production, distribution, and application of biocidal products specifically categorized under Product Type 18 (PT18). These biocides are primarily used as insecticides and repellents designed to control, repel, or eliminate insects and other arthropods in various sectors such as agriculture, healthcare, residential, and industrial settings. PT18 biocides play a critical role in preventing the spread of vector-borne diseases, protecting crops, and maintaining hygiene standards across multiple end-use industries. The market has witnessed substantial growth over recent years, driven by rising awareness of insect-borne diseases, increasing agricultural activities, and stringent regulatory frameworks aimed at enhancing public health and safety.

Market players are focusing on the development of eco-friendly and sustainable biocidal solutions to meet evolving consumer preferences and regulatory compliance. The demand for PT18 biocides is particularly strong in emerging economies due to expanding agricultural output and urbanization. Additionally, technological advancements and innovations in formulation are enabling the production of more effective and less toxic insecticidal products. The market landscape is characterized by the presence of key global manufacturers, ongoing research and development, and growing collaborations to address environmental concerns while ensuring efficacy.

Facts & Figures

• Vector-borne diseases cause over 700,000 deaths annually worldwide, according to WHO. PT18 biocides play a key role in controlling vectors like mosquitoes and ticks.
• Dengue affects 3.9 billion people in 129+ countries, with nearly 96 million symptomatic cases yearly. PT18 insecticides are essential in prevention efforts.
• Climate change is expanding vector habitats, making new regions vulnerable to outbreaks. This increases the need for adaptable PT18 vector control strategies.
• WHO promotes Integrated Vector Management (IVM), where PT18 biocides are a core component alongside environmental and biological controls.

Key Developments:

• In November 2024, Prallethrin, a synthetic pyrethroid insecticide, was approved for PT18 use, with the approval effective from March 2026. Due to its classification as very persistent and toxic (vPvB), its market authorization is limited to five years, requiring renewal and strict dossier submission.
• In February 2024, EcoMundo launched a Chrysanthemum-based PT18 biocide consortium to support collaborative BPR submissions. The initiative aims to simplify regulatory processes and reduce individual company costs, with dossier submissions scheduled before January 31, 2025.

Biocide (PT18) Market Segmentation:

Based on the type:

• Synthetic Biocides
• Natural/Bio-based Biocides

The Synthetic Biocides segment is anticipated to lead the market, primarily driven by its high efficacy and cost-effectiveness in controlling a broad spectrum of insect pests. These biocides offer rapid action and long-lasting protection, making them preferred choices in public health and agricultural applications where immediate and reliable insect control is critical. Moreover, synthetic biocides benefit from well-established manufacturing processes and widespread availability, enabling manufacturers to meet large-scale demand efficiently. Despite rising interest in natural alternatives, the superior performance and affordability of synthetic biocides continue to dominate market growth and adoption globally.

Based on the end user:

• Healthcare
• Agriculture
• Food & Beverage
• Hospitality
• Municipal/Government
• Others

The Healthcare segment is expected to dominate the market due to the critical need for maintaining high hygiene standards and controlling disease vectors within medical facilities. Hospitals, clinics, and laboratories rely heavily on PT18 biocides to manage the spread of insects that can carry infections, especially in patient care and surgical areas. With the rise in hospital-acquired infections (HAIs) and increased awareness of infection prevention protocols, demand for effective insecticidal solutions is accelerating. Furthermore, government regulations mandating stringent disinfection practices in healthcare environments continue to drive adoption, solidifying this segment’s leadership in the market.

Based on the distribution channel:

• Direct Sales
• Retail Stores
• Online Platforms
• Distributors/Wholesalers

Direct Sales is anticipated to lead the market as the most dominant distribution channel, particularly due to its ability to facilitate bulk procurement and foster strong relationships between manufacturers and end-users. This channel is highly preferred by institutional buyers such as hospitals, municipalities, and agricultural enterprises that require consistent supply and technical support. Direct sales also enable better pricing control, customized product recommendations, and quicker response to client needs. Manufacturers benefit from enhanced customer loyalty and direct feedback, allowing for product improvement and service optimization, thereby reinforcing the channel’s stronghold across various end-use sectors.